CYCN: Cyclerion Therapeutics, Inc. Stock

by  •  • Comments Off on CYCN: Cyclerion Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.37
Enterprise Value ($M) 5.73
Book Value ($M) 8.78
Book Value / Share 2.74
Price / Book 1.07
NCAV ($M) 3.43
NCAV / Share 1.07
Price / NCAV 2.73

Profitability (mra)
Return on Invested Capital (ROIC) -0.34
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 4.21
Current Ratio 4.21

Balance Sheet (mrq) ($M)
Current Assets 4.50
Assets 9.85
Liabilities 1.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.00
Operating Income -3.63
Net Income -3.06
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.33
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A Tyndall Capital Partners L P 5.10 0.21
03-28 13D/A Hecht Peter M 27.90 22.26
02-12 13G/A American Endowment Foundation 4.91 -95.00
02-12 13G/A Fmr Llc 0.20 -97.09
12-06 13G/A Slate Path Capital LP 0.00 -100.00
07-12 13G/A Artal International S.C.A. 4.30 -16.41

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 1,489 4,867 30.59
2025-05-14 2,676 9,355 28.61
2025-05-13 4,122 15,365 26.83

(click for more detail)

Similar Companies
CUE – Cue Biopharma, Inc. CVKD – Cadrenal Therapeutics, Inc.
CYCC – Cyclacel Pharmaceuticals, Inc. CYRX – Cryoport, Inc.
DARE – Daré Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io